Bg pattern

SOÑODOR DIPHENHYDRAMINE 50 mg TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use SOÑODOR DIPHENHYDRAMINE 50 mg TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show translation

Introducción

Prospecto: información para el usuario

Soñodor difenhidramina 50 mg comprimidos

Difenhidramina hidrocloruro

Lea todo el prospecto detenidamente antes de empezar a tomar este medicamento porque contiene información importante para usted.

Siga exactamente las instrucciones de administración del medicamento contenidas en este prospecto o las indicadas por su médico o farmacéutico.

  • Conserve este prospecto, ya que puede tener que volver a leerlo.
  • Si necesita consejo o más información, consulte a su farmacéutico.
  • Si experimenta efectos adversos, consulte a su médico o farmacéutico, incluso si se trata de efectos adversos que no aparecen en este prospecto. Ver sección 4.
  • Debe consultar a un médico si empeora o si no mejora después de 7 días.

Contenido del prospecto

  1. Qué es Soñodor difenhidramina y para qué se utiliza
  2. Qué necesita saber antes de tomar Soñodor difenhidramina
  3. Cómo tomar Soñodor difenhidramina
  4. Posibles efectos adversos

5 Conservación de Soñodor difenhidramina

  1. Contenido del envase e información adicionall

1. Qué es Soñodor difenhidramina y para qué se utiliza

Soñodor difenhidramina 50 mg comprimidos está indicado en adultos en el tratamiento sintomático del insomnio ocasional, particularmente cuando existe dificultad para conciliar el sueño, como en situaciones de intranquilidad, en frecuentes interrupciones durante el sueño o despertar temprano por la mañana.

Debe consultar a un médico si empeora o si no mejora después de 7 días.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. Qué necesita saber antes de empezar a tomar Soñodor difenhidramina

No tome Soñodor difenhidramina:

  • si es alérgico a difenhidramina hidrocloruro o a alguno de los demás componentes de este medicamento (incluidos en la sección 6),
  • si padece asma,
  • si padece dificultad para respirar,
  • si padece enfisema pulmonar crónico (enfermedad pulmonar grave),
  • si padece glaucoma (aumento de la presión intraocular),
  • si padece dificultad para orinar debido a problemas de próstata,
  • si está embarazada o en periodo de lactancia.

Advertencias y precauciones

Consulte a su médico o farmacéutico antes de empezar a tomar Soñodor difenhidramina.

Se recomienda la administración del medicamento únicamente antes de acostarse. No deberá ser administrado durante un periodo superior a 7 días, ni a menores de 18 años, si no es con conocimiento o recomendación del médico, ya que el insomnio puede ser síntoma de otra enfermedad más importante. Si aparece somnolencia a la mañana siguiente, disminuir la dosis.

Niños y adolescentes

Soñodor difenhidramina sólo podrá ser utilizado en jóvenes entre 12 y 18 años bajo recomendación médica.

No se ha establecido la seguridad y eficacia de Soñodor difenhidraminaen niños menores de 12 años. No se dispone de datos.

Otros medicamentos y Soñodor difenhidramina

Informe a su médico o farmacéutico si está utilizando, ha utilizando recientemente o pudiera tener que utilizar cualquier otro medicamento.

Soñodor difenhidramina no debe administrarse conjuntamente con alcohol, sedantes, tranquilizantes u otras sustancias depresoras de Sistema Nervioso, por un posible efecto suma. Los antidepresivos IMAO (inhibidores de la monoamino-oxidasa) pueden prolongar e intensificar los efectos anticolinérgicos de la difenhidramina, por lo que si está en tratamiento con alguno de ellos, debe consultar a su médico antes de tomar este medicamento.

Interferencias en el diagnóstico: Soñodor difenhidramina puede interferir con las pruebas cutáneas que utilizan alergenos. Se recomienda suspender esta medicación al menos 3 días antes de comenzar dichas pruebas e informar al médico.

Toma de Soñodor difenhidramina con alimentos, bebidas y alcohol

La ingesta de alcohol junto con Soñodor difenhidramina puede intensificar el efecto del medicamento.

Embarazo, lactancia y fertilidad

Si está embarazada o en periodo de lactancia, cree que podría estar embarazada o tiene intención de quedarse embarazada, consulte a su médico o farmacéutico antes de utilizar este medicamento.

No administrar durante el embarazo, especialmente durante el primer y último trimestre, salvo que, según criterio médico, los beneficios justifiquen los posibles riesgos.

No administrar durante el periodo de lactancia.

Conducción y uso de máquinas

No conduzca ni maneje herramientas o máquinas durante el tratamiento con Soñodor difenhidramina porque este medicamento produce somnolencia.

Soñodor difenhidramina contiene lactosa

Este medicamento contiene lactosa. Si su médico le ha indicado que padece una intolerancia a ciertos azúcares, consulte con él antes de tomar este medicamento.

3. Cómo tomar Soñodor difenhidramina

Siga exactamente las instrucciones de administración de este medicamentoindicadas por su médico o farmecéutico. En caso de duda, consulte de nuevo a su médico o farmacéutico.

Soñodor difenhidramina se administra por vía oral. Tragar los comprimidos con ayuda de algún líquido, 20-30 minutos antes de acostarse.

La dosis recomendada es:

  • Adultos: 1 comprimido al día (50 mg)

Uso en niños y adolescentes

  • Sólo podrá ser utilizado en adolescentes entre 12 y 18 años bajo recomendación médica.

Adolescentes entre 12 y 18 años: La dosis recomendada es de medio comprimido al día (25 mg), siempre bajo recomendación médica.

Los comprimidos se pueden dividir en dos mitades iguales.

  • No administrar a menores de 12 años. No se ha establecido la seguridad y eficacia de Soñodor difenhidramina en niños menores de 12 años. No se dispone de datos.

Si toma más Soñodor difenhidramina del que debe

En caso de sobredosis o ingestión accidental, consulte inmediatamente a su médico o farmacéutico o llame al Servicio de Información Toxicológica, teléfono:91 562 04 20, indicando el medicamento y cantidad ingerida.

Si olvidó tomar Soñodor difenhidramina

No tome una dosis doble para compensar las dosis olvidadas.

Si tiene cualquier otra duda sobre el uso de este medicamento, pregunte a su médico o farmacéutico.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Posibles efectos adversos

Al igual que todos los medicamentos, este medicamento puede producir efectos adversos, aunque no todas las personas los sufran.

Tras la administración de difenhidramina hidrocloruro, se han registrado las siguientes reacciones adversas cuya frecuencia no se puede establecer con exactitud:

Ocasionalmente, puede presentarse diarrea, anorexia (falta de apetito), molestias o dolores de estómago, estreñimiento, dificultad para orinar, vértigo, confusión, sequedad de boca y visión borrosa.

Raramente se han descrito temblores, rash cutáneo (erupción en la piel) y fotosensibilidad.

Excepcionalmente se han descrito determinadas alteraciones de la sangre tales como leucopenia, trombocitopenia y anemia hemolítica.

En la mayoría de los casos los efectos adversos referidos han sido leves y no han requerido la suspensión del tratamiento.

Comunicación de efectos adversos

Si experimenta cualquier tipo de efecto adverso, consulte a su médico o farmacéutico, incluso si se trata de posibles efectos adversos que no aparecen en este prospecto. También puede comunicarlos directamente a través del Sistema Español de Farmacovigilancia de Medicamentos de Uso Humano: https://www.notificaram.es. Mediante la comunicación de efectos adversos usted puede contribuir a proporcionar más información sobre la seguridad de este medicamento.

5. Conservación de Soñodor Difenhidramina

Mantener este medicamento fuera de la vista y del alcance de los niños.

No requiere condiciones especiales de conservación.

No utilice este medicamento después de la fecha de caducidad que aparece en el envase después de CAD. La fecha de caducidad es el último día del mes que se indica después de CAD.

Los medicamentos no se deben tirar por los desagües ni a la basura. Deposite los envases y los medicamentos que no necesita en el Punto SIGRE de la farmacia.Pregunte a su farmacéutico cómo deshacerse de los envases y de los medicamentos que ya no necesita. De esta forma, ayudará a proteger el medio ambiente.

6. Contenido del envase e información adicional

Composición de Soñodor difenhidramina

  • El principio activo es difenhidramina hidrocloruro. Cada comprimido contiene 50 mg de difenhidramina hidrocloruro.
  • Los demás componentes (excipientes) son lactosa monohidrato, celulosa microcristalina, ácido esteárico, sílice coloidal anhidra y estearato de magnesio.

Aspecto del producto y contenido del envase

Comprimidos ranurados para administración oral.

Los comprimidos se pueden dividir en dos mitades iguales.

Soñodor difenhidramina se presenta en tiras de aluminio-polietileno en estuches con 10 y 16 comprimidos.

Titular de la autorización de comercialización y responsable de la fabricación

Laboratorios Urgo S.L. - C/Florida, 29 - 20120 HERNANI (Guipúzcoa) España

Fecha de la última revisión de este prospecto: 05/2017

La información detallada y actualizada de este medicamento está disponible en la página Web de la Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) http://www.aemps.gob.es/

Online doctors for SOÑODOR DIPHENHYDRAMINE 50 mg TABLETS

Discuss questions about SOÑODOR DIPHENHYDRAMINE 50 mg TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (5)
Doctor

Anastasiia Hladkykh

Psychiatry 15 years exp.

Dr Anastasiia Hladkykh is a physician-psychotherapist and psychologist with over 14 years of experience working with individuals struggling with various types of addictions and their families. She provides online consultations for adults, combining medical knowledge with deep psychological support and practical tools.

Key areas of expertise:

  • Addiction treatment: alcohol and drug dependence, gambling addiction, compulsive behaviours, codependent relationships.
  • Support for families of addicted individuals, behavioural correction within the family system, guidance for maintaining remission.
  • Mental health: depression, bipolar disorder, obsessive-compulsive disorder (OCD), anxiety disorders, phobias, PTSD, generalised anxiety, emotional trauma, and the psychological impact of loss or emigration.
  • Psychoeducation: explaining complex mental health concepts in simple language, helping patients and their families understand diagnoses and treatment steps.
Therapeutic approach:
  • Client-centred, straightforward, and empathetic – focused on practical outcomes and emotional stabilisation.
  • Prescribes medications when needed, but always aims to minimise unnecessary pharmaceutical use.
  • Certified in multiple evidence-based methods: CBT, NLP (Master Practitioner), Ericksonian hypnosis, symbol drama, art therapy, and systemic therapy.
  • Each consultation results in a clear, structured plan – patients leave knowing exactly what to do next.
Experience and background:
  • Member of the German association Gesundheitpraktikerin and the NGO “Mit dem Sonne in jedem Herzen.”
  • More than 18 publications in international peer-reviewed journals, translated into several languages.
  • Volunteer work with Ukrainian refugees and military personnel at the University Clinic of Regensburg.
Camera Book a video appointment
€130
5.0 (17)
Doctor

Anastasiia Shalko

Family medicine 13 years exp.

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.

Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate
Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.

She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.

With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Camera Book a video appointment
€50
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for SOÑODOR DIPHENHYDRAMINE 50 mg TABLETS?
SOÑODOR DIPHENHYDRAMINE 50 mg TABLETS does not require a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
Who manufactures SOÑODOR DIPHENHYDRAMINE 50 mg TABLETS?
SOÑODOR DIPHENHYDRAMINE 50 mg TABLETS is manufactured by Laboratorios Urgo S.L.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of SOÑODOR DIPHENHYDRAMINE 50 mg TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether SOÑODOR DIPHENHYDRAMINE 50 mg TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to SOÑODOR DIPHENHYDRAMINE 50 mg TABLETS?
Other medicines with the same active substance () include DEXDOR 100 micrograms/ml concentrate for infusion solution (25x2 ml), DEXDOR 100 micrograms/ml concentrate for infusion solution, DEXDOR 100 micrograms/ml concentrate for infusion solution. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media